{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:29:54Z","timestamp":1794695394227,"version":"4.9.1"},"reference-count":17,"publisher":"BMJ","issue":"6886","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1993,5,1]]},"abstract":"<jats:p>OBJECTIVE--To evaluate treatment of group A beta haemolytic streptococcal pharyngitis with amoxycillin once daily compared with phenoxymethylpenicillin three or four times a day. DESIGN--Randomised controlled study of consecutive patients presenting with symptoms suggestive of group A beta haemolytic streptococcal pharyngitis in whom culture of a throat swab yielded positive results. SETTING--Five family medicine practices. SUBJECTS--157 patients aged over 3 years who required treatment with antibiotics. MAIN OUTCOME MEASURES--Clinical response, bacteriological response, days at work and school lost, and compliance. RESULTS--During the period of the study 393 patients presented with symptoms suggesting streptococcal pharyngitis; 157 of them had throat swabs that yielded positive results on culture. Eighty two were treated with phenoxymethylpenicillin and 75 with amoxycillin. No difference was observed in the clinical response, days at work and school lost (139 days for 64 patients taking phenoxymethylpenicillin v 100 days for 57 patients taking amoxycillin; p &gt; 0.2), or residual positive cultures after two days (6 (7.3%) v 3 (4%); p &gt; 0.5). A significant difference in the bacteriological response was found after 14 days (5 (6.1%) v 0; p &lt; 0.04) with no positive cultures observed in the amoxycillin group. CONCLUSIONS--These findings support the hypothesis that amoxycillin once daily is as effective as phenoxymethylpenicillin in the treatment of group A beta haemolytic streptococcal pharyngitis.<\/jats:p>","DOI":"10.1136\/bmj.306.6886.1170","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T08:16:37Z","timestamp":1238400997000},"page":"1170-1172","source":"Crossref","is-referenced-by-count":80,"title":["Treatment of streptococcal pharyngitis with amoxycillin once a day."],"prefix":"10.1136","volume":"306","author":[{"given":"P","family":"Shvartzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tabenkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rosentzwaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dolginov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1993,5,1]]},"reference":[{"key":"ref_1","first-page":"504","article-title":"Management of upper respiratory tract infection in Dutch general practice","volume":"41","author":"RA, De Melker; MM, Kuyvenhoven","year":"1991","unstructured":"De Melker RA, Kuyvenhoven MM. Management of upper respiratory tract infection in Dutch general practice. British Journal of General Practice 1991;41:504-7.","journal-title":"British Journal of General Practice"},{"key":"ref_2","first-page":"390","article-title":"Diagnosis and management of streptococcal pharyngitis","volume":"117","author":"Raz, R.; Sharir, R.; Yalin, N.","year":"1989","unstructured":"Raz R, Sharir R, Yalin N. Diagnosis and management of streptococcal pharyngitis. Harefuah 1989;117:390-1.","journal-title":"Harefuah"},{"key":"ref_3","first-page":"133","article-title":"Antibiotic therapy: influence of duration, frequency, route of administration, and compliance","volume-title":"Pharyngitis; management in an era ofdeclining rheumaticfever","author":"HC, Jr, Dillon","year":"1984","unstructured":"Dillon HC Jr. Antibiotic therapy: influence of duration, frequency, route of administration, and compliance. In: Shulman ST, ed. Pharyngitis; management in an era ofdeclining rheumaticfever. New York: Praeger, 1984:133-51."},{"key":"ref_4","first-page":"138","article-title":"Treatment of B-haemolytic streptococcal pharyngitis with cefaclor. j Fam Pract","volume":"32","author":"Reed, B.D.; Huck, W.; Zazove, P.","year":"1991","unstructured":"Reed BD, Huck W, Zazove P. Treatment of B-haemolytic streptococcal pharyngitis with cefaclor. j Fam Pract 1991;32:138-44."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(86)80139-1","article-title":"Once daily therapy for streptococcal pharyngitis with cefadroxil","volume":"109","author":"Gerber, M.A.; Randolph, M.F.; Chanatry, J.; Wright, L.L.; Anderson, L.R.; Kaplan, E.L.","year":"1986","unstructured":"Gerber MA, Randolph MF, Chanatry J, Wright LL, Anderson LR, Kaplan EL. Once daily therapy for streptococcal pharyngitis with cefadroxil. jPediatr 1986;109:531-7.","journal-title":"jPediatr"},{"key":"ref_6","first-page":"263","article-title":"Single daily dose of antidepressants. JAM4","volume":"230","author":"FJJr, Ayd","year":"1974","unstructured":"Ayd FJJr. Single daily dose of antidepressants. JAM4 1974;230:263."},{"key":"ref_7","first-page":"1881","article-title":"The effect of prescribed daily dose frequency on patient medication compliance","volume":"50","author":"Eisen, S.A.; Miller, D.K.; Woodward, R.S.; Spitznagel, E.; Pnzybeck, T.R.","year":"1990","unstructured":"Eisen SA, Miller DK, Woodward RS, Spitznagel E, Pnzybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;l50:1881-4.","journal-title":"Arch Intern Med"},{"key":"ref_8","first-page":"125","article-title":"Penicillin in streptococcal infections: total dose and frequency of administration","volume":"1","author":"Breese, B.B.; Disney, F.A.; Talpez, W.B.","year":"1965","unstructured":"Breese BB, Disney FA, Talpez WB. Penicillin in streptococcal infections: total dose and frequency of administration. AmJDis Child 1965;l1O:125-30.","journal-title":"AmJDis Child"},{"key":"ref_9","first-page":"153","article-title":"Failure of once daily penicillin V therapy for streptococcal pharyngitis","volume":"143","author":"Gerber, M.A.; Randolph, M.F.; DeMeo, K.; HM, Jr, Feder; Kaplan, E.L.","year":"1989","unstructured":"Gerber MA, Randolph MF, DeMeo K, Feder HM Jr, Kaplan EL. Failure of once daily penicillin V therapy for streptococcal pharyngitis. Am I Dis Child 1989;143:153-5.","journal-title":"Am I Dis Child"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198702193160801","article-title":"Resurgence of acute rheumatic fever in the intermountain area of the United States","volume":"316","author":"Veasy, L.G.; Weidmeier, S.E.; Orsmond, G.S.; Ruttenberg, H.D.; Boucek, M.M.; Roth, S.J.","year":"1987","unstructured":"Veasy LG, Weidmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, Roth SJ, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. NEnglJMed 1987;316:421-7.","journal-title":"NEnglJMed"},{"key":"ref_11","first-page":"730","article-title":"Resurgence of acute rheumatic fever","volume":"141","author":"Hosier, D.M.; Craenen, J.M.; Teske, D.W.; nI, Wheller","year":"1987","unstructured":"Hosier DM, Craenen JM, Teske DW, Wheller nI. Resurgence of acute rheumatic fever. AmIDis Child 1987;141:730-3.","journal-title":"AmIDis Child"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.1989.03430180099037","article-title":"The return of acute rheumatic fever in young adults","volume":"262","author":"Wallace, M.R.; Garst, P.D.; Papadimos, T.J.; EC, III, Oldfield","year":"1989","unstructured":"Wallace MR, Garst PD, Papadimos TJ, Oldfield EC III. The return of acute rheumatic fever in young adults.JAMA 1989;262:2557-61.","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A streptococcal infections associated with a toxic shock like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens, D.L.; Tanner, M.H.; Winship, J.; Swarts, R.; Ries, K.M.; Schlievert, P.M.","year":"1989","unstructured":"Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shock like syndrome and scarlet fever toxin A. NEnglJMed 1989;321:1-7.","journal-title":"NEnglJMed"},{"key":"ref_14","first-page":"255","article-title":"Diagnosis, antibiotic treatment and outcome of acute tonsillitis: report of a WHO regional office for Europe study in 17 European countries. Fam Pract","volume":"9","author":"Touw-Otten, F.W.; Johansen, K.S.","year":"1992","unstructured":"Touw-Otten FW, Johansen KS. Diagnosis, antibiotic treatment and outcome of acute tonsillitis: report of a WHO regional office for Europe study in 17 European countries. Fam Pract 1992;9:255-62."},{"key":"ref_15","article-title":"Drug formulamy. Tel Aviv: Kupat Holim-Health Insurance of the General Federation of Labour in Israel, 1992: 37","author":"Kitzes-Cohen, R.; Goldschmid, A.; Fostick, M.A.","unstructured":"Kitzes-Cohen R, Goldschmid A, Fostick MA. Drug formulamy. Tel Aviv: Kupat Holim-Health Insurance of the General Federation of Labour in Israel, 1992:37."},{"key":"ref_16","article-title":"Martindake-the extra pharmacopoeia","author":"Reynolds, E.F.; Parsons, A.V.; Sweetman, S.C.","unstructured":"Reynolds EF, Parsons AV, Sweetman SC. Martindake-the extra pharmacopoeia. 29th ed. London: The Pharmaceutical Press, 1989:115.","edition":"29th ed"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/clinids\/14.Supplement_2.S218","article-title":"Streptococcal pharyngitis: current therapy and criteria for evaluation ofnew agents","volume":"14","author":"Georges, P.","year":"1992","unstructured":"Georges P. Streptococcal pharyngitis: current therapy and criteria for evaluation ofnew agents. Clinical Infectious Diseases 1992;14(suppl):218-23.","journal-title":"Clinical Infectious Diseases"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.306.6886.1170","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.306.6886.1170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:45:22Z","timestamp":1766425522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.306.6886.1170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5,1]]},"references-count":17,"journal-issue":{"issue":"6886","published-online":{"date-parts":[[1993,5,1]]},"published-print":{"date-parts":[[1993,5,1]]}},"alternative-id":["10.1136\/bmj.306.6886.1170"],"URL":"https:\/\/doi.org\/10.1136\/bmj.306.6886.1170","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5,1]]}}}